Evidence map›Paper›PMID 25118278›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Engineered kinase activation reveals unique morphodynamic phenotypes and associated trafficking for Src family isoforms.

Pei-Hsuan Chu, Denis Tsygankov, Matthew E Berginski, Onur Dagliyan, Shawn M Gomez, Timothy C Elston, Andrei V Karginov, Klaus M Hahn

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Phase separation of YAP-MAML2 differentially regulates the transcriptome.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Engineering Optogenetic Protein Analogs.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  14. Article
  15. Article
  16. Controlling protein conformation with light.Current opinion in structural biology · 2019
    Review
  17. Article
  18. Review
  19. Piezo1 mediates angiogenesis through activation of MT1-MMP signaling.American journal of physiology. Cell physiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Pei-Hsuan ChuDepartment of Pharmacology.
Denis TsygankovDepartment of Pharmacology.
Matthew E BerginskiDepartment of Biomedical Engineering.
Onur DagliyanDepartment of Pharmacology, Department of Biochemistry and Biophysics, and.
Shawn M GomezDepartment of Biomedical Engineering.ORCID http://orcid.org/0000-0002-8251-4552
Timothy C ElstonDepartment of Pharmacology.
Andrei V KarginovDepartment of Pharmacology, khahn@med.unc.edu karginov@uic.edu.
Klaus M HahnDepartment of Pharmacology, Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 khahn@med.unc.edu karginov@uic.edu.
Institute of Molecular Biology and Biophysics · RUUniversity of North Carolina at Chapel Hill · US

Funding

Tissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KATHERINE A. HOADLEY · 1992 to 2026
$59.3M
Assemby , dynamics and evolution of cell-cell and cell-matrix adhesionsU01GM094663 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI WEIS, WILLIAM I · 2010 to 2014
$6.4M
A toolkit for imaging and photo-manipulation of signaling in zebrafishR01GM102924 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HAHN, KLAUS M., HUTTENLOCHER, ANNA · 2012 to 2015
$2.5M
New methods for activation of kinases and kinase circuits in living cells.R21CA159179 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARGINOV, ANDREI V · 2012 to 2013
$371k
Howard Hughes Medical InstituteNCI NIH HHS P50 CA058223NCI NIH HHS R21 CA159179NCI NIH HHS R21CA159179NIGMS NIH HHS R01 GM102924NIGMS NIH HHS U01 GM094663NIGMS NIH HHS U01GM094663PHS HHS GMO79271
6 · The paper itself

Abstract

The Src kinase family comprises nine homologous members whose distinct expression patterns and cellular distributions indicate that they have unique roles. These roles have not been determined because genetic manipulation has not produced clearly distinct phenotypes, and the kinases' homology complicates generation of specific inhibitors. Through insertion of a modified FK506 binding protein (insertable FKBP12, iFKBP) into the protein kinase isoforms Fyn, Src, Lyn, and Yes, we engineered kinase analogs that can be activated within minutes in living cells (RapR analogs). Combining our RapR analogs with computational tools for quantifying and characterizing cellular dynamics, we demonstrate that Src family isoforms produce very different phenotypes, encompassing cell spreading, polarized motility, and production of long, thin cell extensions. Activation of Src and Fyn led to patterns of kinase translocation that correlated with morphological changes in temporally distinct stages. Phenotypes were dependent on N-terminal acylation, not on Src homology 3 (SH3) and Src homology 2 (SH2) domains, and correlated with movement between a perinuclear compartment, adhesions, and the plasma membrane.

Indexed as

AcylationAmino Acid SequenceAmino Acid SubstitutionAnimalsBiophysical PhenomenaChlorocebus aethiopsCOS CellsEnzyme ActivationIsoenzymesModels, MolecularMolecular Sequence DataMutagenesis, Site-DirectedPhenotypeProtein EngineeringProto-Oncogene Proteins c-fynRecombinant Fusion ProteinsIsoenzymesProto-Oncogene Proteins c-fynRecombinant Fusion Proteinssrc-Family KinasesTacrolimus Binding Protein 1Aimage analysislive cell imagingmotion classificationprotein engineeringrapamycin

Identifiers

PMID25118278
PMCPMC4151743
OpenAlexW2006560015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.